文献速递心力衰竭与心肌病

射血分数降低心衰患者收缩功能改善的相关参数

Parameters associated with improvement of systolic function in patients with heart failure.
PubMed 文献 · Heart · 2023-12-15

该回顾性队列研究分析了686例HFrEF门诊患者,发现81.5%的患者LVEF改善,14.6%为超反应者。基线全局纵向应变、三尖瓣环收缩期位移、左室舒张末内径、E/A比值、心率、缺血性心肌病和糖尿病与LVEF改善独立相关,且LVEF改善越大死亡风险越低。

要点

  • 多数HFrEF门诊患者经治疗LVEF可改善,超反应者占14.6%。
  • 基线应变、右室功能、左室大小、E/A、心率、病因及糖尿病与LVEF改善相关。
  • LVEF改善越大,死亡风险显著降低。

核心结论

  • 在该HFrEF门诊队列中,大多数患者收缩功能改善。
  • 心衰病因、合并症及心脏结构和功能的超声指标与未来LVEF改善独立相关。
  • LVEF改善程度越大,死亡风险显著降低。

研究设计与样本

  • 回顾性队列研究,纳入686例于Gentofte医院心衰门诊就诊的HFrEF患者。
  • 调取首次和末次超声心动图检查进行分析。
  • 采用线性回归评估与LVEF改善相关的参数,采用Cox回归评估LVEF改善与生存的关系。

主要发现

  • 559例(81.5%)患者LVEF改善(ΔLVEF>0%),100例(14.6%)为超反应者(LVEF改善>20%)。
  • 多变量调整后,LVEF改善与较不 impaired 的全局纵向应变(β系数0.25,p<0.001)、较高的三尖瓣环收缩期位移(β系数0.09,p=0.018)、较小的左室舒张末内径(β系数-0.15,p=0.011)、较低的E/A比值(β系数-0.13,p=0.003)、较高的心率(β系数0.18,p<0.001)、无缺血性心肌病(β系数-0.11,p=0.010)及无糖尿病(β系数-0.081,p=0.033)显著相关。
  • ΔLVEF<0%与ΔLVEF>0%的死亡率分别为8.3 vs 4.3/100人年(p=0.012)。
  • LVEF改善越大死亡风险越低(三分位1 vs 三分位3,HR 3.23,95%CI 1.39-7.51,p=0.006)。

临床怎么用

  • 对HFrEF门诊患者应积极优化治疗,多数患者收缩功能可改善。
  • 基线超声指标(应变、右室功能、左室大小、E/A)及病因、合并症有助于识别LVEF改善可能性高的患者。
  • LVEF改善可作为降低死亡风险的替代指标,鼓励监测LVEF变化。

局限性

  • 回顾性队列研究,可能存在选择偏倚和未测量混杂。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Identifying clinical and echocardiographic parameters associated with improvement in systolic function in outpatients with heart failure with reduced ejection fraction (HFrEF) could lead to more targeted treatment improving systolic function and outcome. METHODS: In a retrospective cohort study, echocardiographic examinations from the first and final visit of 686 patients with HFrEF at the heart failure clinic at Gentofte Hospital were retrieved and analysed. Parameters associated with left ventricular ejection fraction (LVEF) improvement and survival according to LVEF improvement were assessed using linear regression and Cox regression, respectively. Beta-coefficients (β-coef) are standardised. Strain values are absolute. RESULTS: While undergoing heart failure treatment, 559 (81.5%) patients improved systolic function ( Δ LVEF >0%), with 100 (14.6%) being super responders defined by LVEF improvement >20%. After multivariable adjustment, LVEF improvement was significantly associated with a less impaired global longitudinal strain (β-coef 0.25, p<0.001), higher tricuspid annular plane systolic excursion (β-coef 0.09, p=0.018), smaller left ventricular internal dimension in diastole (β-coef -0.15, p=0.011), lower E-wave/A-wave ratio (β-coef -0.13, p=0.003), higher heart rate (β-coef 0.18, p<0.001) and absence of ischaemic cardiomyopathy (β-coef -0.11, p=0.010) and diabetes (β-coef -0.081, p=0.033) at baseline. Mortality incidence rates differed with LVEF improvement ( Δ LVEF <0% vs Δ LVEF >0%, 8.3 vs 4.3 per 100 person years, p=0.012). Greater improvement in LVEF was associated with significantly lower mortality risk (tertile 1 vs tertile 3, HR 3.23, 95% CI 1.39 to 7.51, p=0.006). CONCLUSION: In this outpatient HFrEF cohort, most patients improved systolic function. Heart failure aetiology, comorbidities and echocardiographic measures of heart structure and function were significantly, independently associated with future LVEF improvement. Greater LVEF improvement was significantly associated with lower mortality.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Schöps, Sengeløv, Modin, et al. Parameters associated with improvement of systolic function in patients with heart failure. Heart. 2023. PMID: 37423743. doi:10.1136/heartjnl-2023-322371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。